Technology and innovation watch
Share
Teva Pharmaceutical’s business strategy in the United States is based largely on selling generic versions of blockbuster drugs even though the company is liable to lose patent infringement suits filed subsequently by the makers of the propriety versions. Teva assumes a calculated risk that it will lose these cases, and [...]
ShareLONDON -(Dow Jones)- U.K. drug maker Shire PLC (SHP.LN) Friday said its U.S. subsidiary filed a lawsuit there against Teva Pharmaceutical Industries Ltd. ( TEVA), alleging that the Israel-based generic drugs maker infringed two patents for Shire’s hyperactivity medicine Intuniv.
Shire, the U.K.’s third-largest drug company, said its lawsuit results from an [...]
ShareSanofi-Aventis, the world’s third largest drug maker, has approached a US court against Wockhardt for challenging the patents of Allegra (fexofenadine hydrochloride), one of the largest selling anti-allergic drugs in the world.
According to the petition filed by the patent-holders and licensees — Sanofi-Aventis US, Aventisub II and Carderm Capital — in the US District Court [...]
Share
Generic giant Teva (Israel) has announced that the U.S. District Court of Delaware has issued a verdict in its favour by finding U.S. Patent No 5,260,291 unenforceable due to “inequitable conduct”. The indicated patent belongs to Merck &Co (U.S.) and protects the intellectual property rights on brain tumor drug Temodar (temozolomide). Merck has revealed that [...]
ShareDrug major Merck & Co said Tuesday that the U.S. District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc. The suit is related to Merck’s chemotherapeutic agent Temodar’s patent.
The company said that in the ruling, Judge Sue Robinson said that Merck’s patent on [...]
ShareAbbott Laboratories asked a federal court to block Teva Pharmaceutical Industries Ltd from making a generic version of Abbott’s Simcor cholesterol treatment, according to court documents.
Abbott said its patents were violated when Israel-based Teva filed an application with the U.S. Food and Drug Administration seeking approval to market a generic version of Simcor, according to [...]
ShareClaiming patent infringement, Pfizer Inc. has filed a complaint in the US District Court in Delaware, requesting an injunction to block Teva Pharmaceutical Industries Ltd from selling a generic form of its Zyvox antibiotic. The move follows Teva’s filing an abbreviated new drug application with the US Food and Drug Administration, seeking regulatory approval, which Pfizer claims is [...]
SharePharmaceutical firm Shire has settled its lawsuit with Teva Pharmaceutical Industries over the supply of raw materials for the attention deficit hyperactivity disorder drug Adderall XR.
The settlement was reached after Teva agreed to drop its lawsuit which claimed that Shire was failing to meet an agreement to provide it with sufficient amphetamines to produce the [...]